![Keri Hildick](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Keri Hildick
Corporate Officer/Principal bei Perspectum Group Ltd.
Aktive Positionen von Keri Hildick
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Perspectum Group Ltd.
![]() Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | 01.07.2015 | - |
Karriereverlauf von Keri Hildick
Ausbildung von Keri Hildick
University of Bristol | Doctorate Degree |
The University of Edinburgh | Undergraduate Degree |
Statistik
International
Vereinigtes Königreich | 4 |
Operativ
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Consumer Services | 3 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Perspectum Group Ltd.
![]() Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Technology Services |
- Börse
- Insiders
- Keri Hildick
- Erfahrung